Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleFocus on Molecular Imaging

Imaging Agents for PET of Inflammatory Bowel Disease: A Review

Farzaneh Rezazadeh, Aidan P. Kilcline and Nerissa T. Viola
Journal of Nuclear Medicine November 2023, jnumed.123.265935; DOI: https://doi.org/10.2967/jnumed.123.265935
Farzaneh Rezazadeh
Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aidan P. Kilcline
Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nerissa T. Viola
Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Additional Files
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Immuno-PET imaging of cell-surface molecules. (A) Immuno-PET directed to CD4+ T cells for imaging colitis. Representative CT and PET/CT images of healthy and DSS-induced colitis mice were acquired 20 h after injection of [89Zr]Zr-mal-DFO-GK1.5 cys-diabody. Colon of DSS-treated mice showed high uptake of radiotracer, whereas healthy control mice showed little to no uptake in colon. (B) PET imaging of system xC– in mice given DSS (top panel) using [18F]FSPG shows increased tracer uptake in colon (white arrows). Inflammation (black arrows) in the distal colon, sigmoid colon, and rectum (middle panel) was delineated by same tracer in 55-y-old male UC patient, as shown in maximum-intensity projection images. Axial PET images (bottom, left) provide semiquantitative measurement of tracer uptake, which correlates with endoscopic image of colon (bottom, right). (C) [89Zr]Zr-α-CD11b PET imaging of colonic inflammation. Shown are representative PET images of DSS and healthy mice after injection of radiotracer. Increased uptake of [89Zr]Zr-α-CD11b was observed in inflamed colon compared with control. ALN = axillary lymph node; B = bone; Bl = bladder; CLN = cervical lymph node; ILN = inguinal lymph node; Ki = kidney; Li = liver; MIP = maximum-intensity projection; MLN = mesenteric lymph node; Pa = pancreas; PLN = popliteal lymph node; Sp= spleen; St = stomach; Ur = ureter. (Reprinted from (5,12,13).)

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Immuno-PET imaging of inflammatory cytokines in IBD. (A) Immuno-PET imaging of TNF-α in colitis mice. Shown are representative PET images of control, DSS-treated, and blocked DSS-treated mice at different time points after injection of [89Zr]Zr-DFO-infliximab. Tracer clearly delineated inflamed colon as early as 2 h after injection. (Reprinted with permission of (14).) (B) [89Zr]Zr-a-IL-1β PET imaging of colonic inflammation. Shown are representative PET images of DSS and healthy mice acquired 24 h after injection of tracer. (Reprinted from (5).) (C) Immuno-PET/CT imaging of IL-12/23p40 in healthy and DSS-treated mice. Shown are representative PET/CT (maximum-intensity projection) images of healthy and colitis mice acquired at 24 and 48 h after injection of [89Zr]Zr-DFO-anti-IL-12/23p40. Tracer clearly delineated intestinal inflammation. (Reprinted from (34).) Li = liver.

Additional Files

  • Figures
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Imaging Agents for PET of Inflammatory Bowel Disease: A Review
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Imaging Agents for PET of Inflammatory Bowel Disease: A Review
Farzaneh Rezazadeh, Aidan P. Kilcline, Nerissa T. Viola
Journal of Nuclear Medicine Nov 2023, jnumed.123.265935; DOI: 10.2967/jnumed.123.265935

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Imaging Agents for PET of Inflammatory Bowel Disease: A Review
Farzaneh Rezazadeh, Aidan P. Kilcline, Nerissa T. Viola
Journal of Nuclear Medicine Nov 2023, jnumed.123.265935; DOI: 10.2967/jnumed.123.265935
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • PATHOGENESIS OF IBD
    • CURRENT APPROACHES FOR IMAGING IBD
    • INFLAMMATORY BIOMARKERS FOR MOLECULAR IMAGING OF IBD
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • From Genome to Phenome: Opportunities and Challenges of Molecular Imaging
  • Imaging the Activity of Efflux Transporters at the Blood–Brain Barrier in Neurologic Diseases: Radiotracer Selection Criteria
  • Molecular Imaging of Pulmonary Fibrosis
Show more Focus on Molecular Imaging

Similar Articles

Keywords

  • inflammatory bowel disease
  • PET
  • noninvasive imaging
  • inflammation
SNMMI

© 2025 SNMMI

Powered by HighWire